Cargando…
Clinical Efficacy and Safety of Vancomycin Continuous Infusion in Patients Treated at Home in an Outpatient Parenteral Antimicrobial Therapy Program
Vancomycin is commonly used in outpatient parenteral antimicrobial therapy (OPAT) of Gram-positive infections. Therapeutic drug monitoring and adverse event monitoring pose a challenge. Outcome data of vancomycin in OPAT (vOPAT) are limited. The study aim was to report the safety and efficacy of a s...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9137986/ https://www.ncbi.nlm.nih.gov/pubmed/35625346 http://dx.doi.org/10.3390/antibiotics11050702 |
_version_ | 1784714514719047680 |
---|---|
author | Thijs, Lore Quintens, Charlotte Vander Elst, Lotte De Munter, Paul Depypere, Melissa Metsemakers, Willem-Jan Vles, Georges Liesenborghs, Astrid Neefs, Jens Peetermans, Willy E. Spriet, Isabel |
author_facet | Thijs, Lore Quintens, Charlotte Vander Elst, Lotte De Munter, Paul Depypere, Melissa Metsemakers, Willem-Jan Vles, Georges Liesenborghs, Astrid Neefs, Jens Peetermans, Willy E. Spriet, Isabel |
author_sort | Thijs, Lore |
collection | PubMed |
description | Vancomycin is commonly used in outpatient parenteral antimicrobial therapy (OPAT) of Gram-positive infections. Therapeutic drug monitoring and adverse event monitoring pose a challenge. Outcome data of vancomycin in OPAT (vOPAT) are limited. The study aim was to report the safety and efficacy of a structured vOPAT program implemented in the University Hospitals Leuven. The program provides continuous elastomeric infusion of vancomycin at home with biweekly follow-up at the outpatient clinic. Demographics, clinical, biochemical and treatment parameters, target attainment parameters and clinical outcomes were recorded. An e-survey was conducted to assess patient satisfaction. Thirty-five vOPAT episodes in 32 patients were included. During 206 follow-up consultations, 203 plasma concentration measurements were registered with a median vancomycin plasma concentration of 22.5 mg/L (range 6.6–32.0). The majority of concentrations (68.5%) were within the therapeutic range (20.0–25.0 mg/L). Adverse event rates, including drug- (5.7%) and catheter-related (5.7%) events, were low. For 32 vOPAT episodes, a clinical cure rate of 100% was observed. All patients who completed the e-survey were satisfied with their vOPAT course. These findings show that a structured vOPAT program with rigorous follow-up provides safe and effective ambulatory treatment of patients with vancomycin in continuous infusion. |
format | Online Article Text |
id | pubmed-9137986 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-91379862022-05-28 Clinical Efficacy and Safety of Vancomycin Continuous Infusion in Patients Treated at Home in an Outpatient Parenteral Antimicrobial Therapy Program Thijs, Lore Quintens, Charlotte Vander Elst, Lotte De Munter, Paul Depypere, Melissa Metsemakers, Willem-Jan Vles, Georges Liesenborghs, Astrid Neefs, Jens Peetermans, Willy E. Spriet, Isabel Antibiotics (Basel) Article Vancomycin is commonly used in outpatient parenteral antimicrobial therapy (OPAT) of Gram-positive infections. Therapeutic drug monitoring and adverse event monitoring pose a challenge. Outcome data of vancomycin in OPAT (vOPAT) are limited. The study aim was to report the safety and efficacy of a structured vOPAT program implemented in the University Hospitals Leuven. The program provides continuous elastomeric infusion of vancomycin at home with biweekly follow-up at the outpatient clinic. Demographics, clinical, biochemical and treatment parameters, target attainment parameters and clinical outcomes were recorded. An e-survey was conducted to assess patient satisfaction. Thirty-five vOPAT episodes in 32 patients were included. During 206 follow-up consultations, 203 plasma concentration measurements were registered with a median vancomycin plasma concentration of 22.5 mg/L (range 6.6–32.0). The majority of concentrations (68.5%) were within the therapeutic range (20.0–25.0 mg/L). Adverse event rates, including drug- (5.7%) and catheter-related (5.7%) events, were low. For 32 vOPAT episodes, a clinical cure rate of 100% was observed. All patients who completed the e-survey were satisfied with their vOPAT course. These findings show that a structured vOPAT program with rigorous follow-up provides safe and effective ambulatory treatment of patients with vancomycin in continuous infusion. MDPI 2022-05-23 /pmc/articles/PMC9137986/ /pubmed/35625346 http://dx.doi.org/10.3390/antibiotics11050702 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Thijs, Lore Quintens, Charlotte Vander Elst, Lotte De Munter, Paul Depypere, Melissa Metsemakers, Willem-Jan Vles, Georges Liesenborghs, Astrid Neefs, Jens Peetermans, Willy E. Spriet, Isabel Clinical Efficacy and Safety of Vancomycin Continuous Infusion in Patients Treated at Home in an Outpatient Parenteral Antimicrobial Therapy Program |
title | Clinical Efficacy and Safety of Vancomycin Continuous Infusion in Patients Treated at Home in an Outpatient Parenteral Antimicrobial Therapy Program |
title_full | Clinical Efficacy and Safety of Vancomycin Continuous Infusion in Patients Treated at Home in an Outpatient Parenteral Antimicrobial Therapy Program |
title_fullStr | Clinical Efficacy and Safety of Vancomycin Continuous Infusion in Patients Treated at Home in an Outpatient Parenteral Antimicrobial Therapy Program |
title_full_unstemmed | Clinical Efficacy and Safety of Vancomycin Continuous Infusion in Patients Treated at Home in an Outpatient Parenteral Antimicrobial Therapy Program |
title_short | Clinical Efficacy and Safety of Vancomycin Continuous Infusion in Patients Treated at Home in an Outpatient Parenteral Antimicrobial Therapy Program |
title_sort | clinical efficacy and safety of vancomycin continuous infusion in patients treated at home in an outpatient parenteral antimicrobial therapy program |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9137986/ https://www.ncbi.nlm.nih.gov/pubmed/35625346 http://dx.doi.org/10.3390/antibiotics11050702 |
work_keys_str_mv | AT thijslore clinicalefficacyandsafetyofvancomycincontinuousinfusioninpatientstreatedathomeinanoutpatientparenteralantimicrobialtherapyprogram AT quintenscharlotte clinicalefficacyandsafetyofvancomycincontinuousinfusioninpatientstreatedathomeinanoutpatientparenteralantimicrobialtherapyprogram AT vanderelstlotte clinicalefficacyandsafetyofvancomycincontinuousinfusioninpatientstreatedathomeinanoutpatientparenteralantimicrobialtherapyprogram AT demunterpaul clinicalefficacyandsafetyofvancomycincontinuousinfusioninpatientstreatedathomeinanoutpatientparenteralantimicrobialtherapyprogram AT depyperemelissa clinicalefficacyandsafetyofvancomycincontinuousinfusioninpatientstreatedathomeinanoutpatientparenteralantimicrobialtherapyprogram AT metsemakerswillemjan clinicalefficacyandsafetyofvancomycincontinuousinfusioninpatientstreatedathomeinanoutpatientparenteralantimicrobialtherapyprogram AT vlesgeorges clinicalefficacyandsafetyofvancomycincontinuousinfusioninpatientstreatedathomeinanoutpatientparenteralantimicrobialtherapyprogram AT liesenborghsastrid clinicalefficacyandsafetyofvancomycincontinuousinfusioninpatientstreatedathomeinanoutpatientparenteralantimicrobialtherapyprogram AT neefsjens clinicalefficacyandsafetyofvancomycincontinuousinfusioninpatientstreatedathomeinanoutpatientparenteralantimicrobialtherapyprogram AT peetermanswillye clinicalefficacyandsafetyofvancomycincontinuousinfusioninpatientstreatedathomeinanoutpatientparenteralantimicrobialtherapyprogram AT sprietisabel clinicalefficacyandsafetyofvancomycincontinuousinfusioninpatientstreatedathomeinanoutpatientparenteralantimicrobialtherapyprogram |